Substituted N-Phenyl-5-(2-(phenylamino)thiazol-4-yl)isoxazole-3-carboxamides Are Valuable Antitubercular Candidates that Evade Innate Efflux Machinery-Reference-Cited by-同舟云学术

Substituted N-Phenyl-5-(2-(phenylamino)thiazol-4-yl)isoxazole-3-carboxamides Are Valuable Antitubercular Candidates that Evade Innate Efflux Machinery

Published:2017-08-10 Issue:16 Volume:60 Page:7108-7122
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Azzali Elisa¹^ORCID,Machado Diana²,Kaushik Amit³⁴,Vacondio Federica,Flisi Sara⁵,Cabassi Clotilde Silvia⁵,Lamichhane Gyanu³⁴,Viveiros Miguel²,Costantino Gabriele,Pieroni Marco^ORCID

Affiliation:

1. Centro Interdipartimentale Misure (CIM) ‘G. Casnati’, University of Parma, Parco Area delle Scienze 23/A, 43124 Parma, Italy

2. Global Health and Tropical Medicine, GHTM, Instituto de Higiene e Medicina Tropical, IHMT, Universidade Nova de Lisboa, UNL, Rua da Junqueira, 100, 1349-008 Lisbon, Portugal

3. Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University, 1503 East Jefferson Street, Baltimore, Maryland 21231-1002, United States

4. Taskforce to Study Resistance Emergence & Antimicrobial development Technology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland 21287, United States

5. Department of Veterinary Science, University of Parma, via del Taglio 10, 43126 Parma, Italy

Funder

Funda??o para a Ci?ncia e a Tecnologia

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.7b00793

Reference85 articles.

1. The Top 10 Causes of Death;World Health Organization:Geneva, 2017; http://www.who.int/mediacentre/factsheets/fs310/en/(accessed Feb 16, 2017).

2. Global Tuberculosis Report 2016;World Health Organization:Geneva, 2017; http://www.who.int/tb/publications/global_report/en/(accessed Feb 16, 2017) .

3. Tuberculosis

4. Surveillance of Drug Resistance in Tuberculosis;World Health Organization:Geneva, 2017; http://www.who.int/tb/publications/mdr_surveillance/en/(accessed Feb 16, 2017).

5. Progress in TB drug development and what is still needed

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Access to Isoxazoles via Photo-oxygenation of Furan Tethered α-Azidoketones;The Journal of Organic Chemistry;2024-08-22

2. Aminopyridines in the development of drug candidates against protozoan neglected tropical diseases;Future Medicinal Chemistry;2024-06-10

3. New Triazole-Isoxazole Hybrids as Antibacterial Agents: Design, Synthesis, Characterization, In Vitro, and In Silico Studies;Molecules;2024-05-26

4. New Synthesis of Some Isoxazole Derivatives and Their Antioxidant Properties;Russian Journal of Organic Chemistry;2024-03

5. Preliminary structure−activity relationships analysis on N-(3,5-dichlorophenyl)-4,5-dihydronaphtho[1,2-d]thiazol-2-amine, a disruptor of mycobacterial energetics;Medicinal Chemistry Research;2024-02-17